Tencent invests in Minapharm, an innovative drug research and development company under Lupu Medical.

date
25/09/2025
According to the Qi Cha Cha app, Shanghai Minwei Biotechnology Co., Ltd. recently underwent a change in its business registration, with Guangxi Tencent Entrepreneurial Investment Co., Ltd. being added as a shareholder and the registered capital increasing to approximately 16.16 million yuan. Information from Qi Cha Cha shows that the company was established in 2021, with Zhang Bingfeng as the legal representative. Its business scope includes technology development in the fields of biotechnology and medical technology, and its major shareholder is Leap Medical. Public information indicates that the company focuses on innovative "multi-core macromolecular biopharmaceuticals" and platform development to create innovative drugs with global competitiveness.